This Program Project Grant application has been initiated to develop a team approach to clarify the mechanisms by which local factors regulate bone remodeling, and in particular osteoclastic bone resorption. It is our hypothesis that bone remodeling is mediated by local factors generated in the bone and bone marrow microenvironment, and that osteoporosis results from abnormalities in the interactions between these local factors and bone cells. Recent studies by ourselves and others indicate that these local factors are heterogeneous, and the complete characterization of their effects on bone cells will require a broadly-based approach involving investigators with expertise in widely disparate but related areas.
The specific aims of this application are: 1. To identify the specific cellular and molecular events involved in normal osteoclastic bone resorption, including a) the signaling mechanisms involved in osteoclast activation; b) the expression of proteins related to osteoclast differentiation and bone resorption; c) the activation of TGF beta during resorption, and its regulation; 2. To determine how these cellular and molecular mechanisms are disordered in Paget's disease. We plan to use the rapidly expanding techniques of bone cell biology, protein chemistry and molecular biology to clarify the mechanisms by which these local factors interact with bone cells. Since the expertise required to identify and characterize these various mechanisms will require the attention of investigators with different types of skills, a team approach will be used to unite a number of diverse approaches around the tightly focused goal of clarifying the mechanisms by which local factors regulate normal and abnormal bone remodeling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
5P01AR039529-02
Application #
3092429
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1990-04-01
Project End
1993-03-31
Budget Start
1991-04-20
Budget End
1992-03-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Xu, S C; Harris, M A; Rubenstein, J L et al. (2001) Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2. DNA Cell Biol 20:359-65
Ji, X; Chen, D; Xu, C et al. (2000) Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab 18:132-9
Yoneda, T (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-5
Nishimura, R; Moriyama, K; Yasukawa, K et al. (1998) Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res 13:777-85
Xu, C; Ji, X; Harris, M A et al. (1998) A clonal chondrocytic cell line derived from BMP-2/T antigen-expressing transgenic mouse. In Vitro Cell Dev Biol Anim 34:359-63
Reddy, S V; Roodman, G D (1998) Control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8:1-17
Chen, D; Ji, X; Harris, M A et al. (1998) Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305
Roodman, G D (1998) Osteoclast differentiation and activity. Biochem Soc Trans 26:7-13
Mundy, G R (1997) Growth factors as potential therapeutic agents in osteoporosis. Instr Course Lect 46:495-8
Cody, J D; Singer, F R; Roodman, G D et al. (1997) Genetic linkage of Paget disease of the bone to chromosome 18q. Am J Hum Genet 61:1117-22

Showing the most recent 10 out of 49 publications